MississippiSB 20562026 Regular SessionSenate

Controlled substances; provide for automatic scheduling of certain substance if federal scheduling occurs.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

2 provisions identified: 1 benefits, 1 costs, 0 mixed.

No automatic scheduling for COVID-19 drugs

Starting July 1, 2026, a drug federally scheduled for preventing or treating COVID-19 is not automatically added to Mississippi’s controlled-substance schedules. State criminal and licensing status now depends on Mississippi law or later state action, not automatic placement. This reduces immediate state penalties for makers, distributors, prescribers, and patients when a COVID-19 drug is put on a federal schedule.

Psilocybin medicine gets automatic state controls

Beginning July 1, 2026, Mississippi auto-schedules any pharmaceutical composition that is a crystalline polymorph of psilocybin after the FDA approves it and the DEA schedules it. The drug is added to the matching state schedule on the same date it is placed on the federal schedule, and state fines and penalties apply. This automatic status lasts until lawmakers change the state schedule or the next regular session ends, including the Governor’s veto period. Makers, distributors, prescribers, and patients face state criminal and licensing rules right away.

Sponsors & Cosponsors

Sponsor

Turner-Ford
Affiliation unavailable

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 172 • No: 0

House vote • 3/4/2026

Passed

Yes: 120 • No: 0

Senate vote • 2/5/2026